Rabin Medical Center: Diabetes Mellitus trials

The registry lists 31 Diabetes Mellitus studies with Rabin Medical Center as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1Phase 4 3No phase 26(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin InjectionsRecruitingNCT06966427Not applicable
• The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes PatientsRecruitingNCT05788341
• Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes MellitusRecruitingNCT04834518
• Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept StudiesRecruitingNCT04653961Not applicable
• Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1TerminatedNCT05610722Not applicable
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19TerminatedNCT04371978Phase 3
• Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1CompletedNCT04271228Not applicable
• An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 DiabetesCompletedNCT04269668Not applicable
• Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept StudyTerminatedNCT04014569Not applicable
• Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility StudyCompletedNCT03574558Not applicable
• Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill PatientsCompletedNCT03510078Not applicable
• Group Versus Individual Care in Diabetes ClinicCompletedNCT03353376Not applicable
• Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro StudyCompletedNCT03003806Not applicable
• Chrono Nutrition (CN) Intervention Program in Gestational Diabetes MellitusStatus unknownNCT02916667Not applicable
• Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2CompletedNCT02776696Not applicable
• Patients Perceptions of Using the "Libre" System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat TrialCompletedNCT02776007Not applicable
• Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 DiabetesWithdrawnNCT02733211Not applicable
• Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREAMED TrailCompletedNCT02651181Not applicable
• Gut Microbiome and Gestational Diabetes MellitusCompletedNCT02649374Not applicable
• The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 DiabetesTerminatedNCT02131896Not applicable
• MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals ManagementCompletedNCT01901913Not applicable
• Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's HomeCompletedNCT01726829Not applicable
• MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 DiabetesCompletedNCT01691287Not applicable
• Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 DiabetesCompletedNCT01661192Phase 2
• Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to ClopidogrelStatus unknownNCT01643031Phase 4
• The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 DiabetesCompletedNCT01600664Not applicable
• Treatment Satisfaction of Using OmniPod System Compared With Conventional Insulin Pump in Adults With Type 1 DiabetesCompletedNCT00935129Not applicable
• Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and AdolescentsTerminatedNCT00925977Not applicable
• The Effects of Regular Home Use Vs Diabetic Team- Supported Use of the Medtronic CareLink Therapy Management System.CompletedNCT00814476Phase 4
• Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir InjectionsCompletedNCT00542399Phase 4
• The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.Status unknownNCT00491465Not applicable